These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 1653962)

  • 1. Cyclic nucleotide-dependent protein kinases.
    Scott JD
    Pharmacol Ther; 1991; 50(1):123-45. PubMed ID: 1653962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cAMP-Dependent Protein Kinase and cGMP-Dependent Protein Kinase as Cyclic Nucleotide Effectors.
    Lorenz R; Bertinetti D; Herberg FW
    Handb Exp Pharmacol; 2017; 238():105-122. PubMed ID: 27885524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. cAMP- and cGMP-elevating agents inhibit GPIbα-mediated aggregation but not GPIbα-stimulated Syk activation in human platelets.
    Makhoul S; Trabold K; Gambaryan S; Tenzer S; Pillitteri D; Walter U; Jurk K
    Cell Commun Signal; 2019 Sep; 17(1):122. PubMed ID: 31519182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the inositol 1,4,5-trisphosphate receptor. Cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta.
    Komalavilas P; Lincoln TM
    J Biol Chem; 1996 Sep; 271(36):21933-8. PubMed ID: 8702997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-activation: overriding cAMP/cGMP selectivities of protein kinases in tissues.
    Jiang H; Shabb JB; Corbin JD
    Biochem Cell Biol; 1992 Dec; 70(12):1283-9. PubMed ID: 1338568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS
    Biochem J; 2001 Nov; 360(Pt 1):199-208. PubMed ID: 11696008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic nucleotide signalling in malaria parasites.
    Baker DA; Drought LG; Flueck C; Nofal SD; Patel A; Penzo M; Walker EM
    Open Biol; 2017 Dec; 7(12):. PubMed ID: 29263246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
    Corbin JD; Turko IV; Beasley A; Francis SH
    Eur J Biochem; 2000 May; 267(9):2760-7. PubMed ID: 10785399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Phosphodiesterase 3 mediates cross-talk between the protein kinase- and cGMP- dependent pathways and cyclic AMP metabolism].
    Makuch E; Matuszyk J
    Postepy Hig Med Dosw (Online); 2012 Jul; 66():492-500. PubMed ID: 22922149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action.
    Francis SH; Corbin JD
    Crit Rev Clin Lab Sci; 1999 Aug; 36(4):275-328. PubMed ID: 10486703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation of PKA and PKG signaling nodes by chemical proteomics.
    Corradini E; Heck AJ; Scholten A
    Methods Mol Biol; 2015; 1294():191-201. PubMed ID: 25783887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations of PKA cyclic nucleotide-binding domains reveal novel aspects of cyclic nucleotide selectivity.
    Lorenz R; Moon EW; Kim JJ; Schmidt SH; Sankaran B; Pavlidis IV; Kim C; Herberg FW
    Biochem J; 2017 Jul; 474(14):2389-2403. PubMed ID: 28583991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP.
    Dhanakoti SN; Gao Y; Nguyen MQ; Raj JU
    J Appl Physiol (1985); 2000 May; 88(5):1637-42. PubMed ID: 10797124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of contractile activity in vascular smooth muscle by protein kinases.
    Silver PJ
    Rev Clin Basic Pharm; 1985; 5(3-4):341-95. PubMed ID: 3029813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of cGMP-dependent protein kinase and its specific substrates in the anterior pituitary.
    Li H; Liu JP; Smith R; Robinson PJ
    Mol Cell Endocrinol; 1996 Sep; 122(2):159-71. PubMed ID: 8902846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
    Wilson LS; Guo M; Umana MB; Maurice DH
    Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein phosphorylation catalyzed by cyclic AMP-dependent and cyclic GMP-dependent protein kinases.
    Glass DB; Krebs EG
    Annu Rev Pharmacol Toxicol; 1980; 20():363-88. PubMed ID: 6247960
    [No Abstract]   [Full Text] [Related]  

  • 19. Collagen stimulation of platelets induces a rapid spatial response of cAMP and cGMP signaling scaffolds.
    Margarucci L; Roest M; Preisinger C; Bleijerveld OB; van Holten TC; Heck AJ; Scholten A
    Mol Biosyst; 2011 Jul; 7(7):2311-9. PubMed ID: 21597619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutating protein kinase cAMP-binding sites into cGMP-binding sites. Mechanism of cGMP selectivity.
    Shabb JB; Buzzeo BD; Ng L; Corbin JD
    J Biol Chem; 1991 Dec; 266(36):24320-6. PubMed ID: 1662209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.